Fig. 7

Percentage of cells in each phase before and after treatment with 10h (Q2-3, viable; Q2-4, early apoptotic; Q2-2, late apoptotic; Q2-1, necrotic)
Percentage of cells in each phase before and after treatment with 10h (Q2-3, viable; Q2-4, early apoptotic; Q2-2, late apoptotic; Q2-1, necrotic)